What is PT Diagnos Laboratorium Utama Tbk (DGNS.JK)?

PT Diagnos Laboratorium Utama Tbk (DGNS.JK) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

PT Diagnos Laboratorium Utama Tbk (DGNS.JK)

Stock analysis · JKT · Healthcare · Medical - Diagnostics & Research

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.38

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

PT Diagnos Laboratorium Utama Tbk (DGNS.JK) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About PT Diagnos Laboratorium Utama Tbk

PT Diagnos Laboratorium Utama Tbk delivers comprehensive medical laboratory services across Indonesia. The company offers a wide range of diagnostic tests, including clinical pathology services covering hematology, hemostasis, clinical chemistry, urinalysis, biomolecular analysis, immunology, and microbiology. It also performs anatomical pathology for the detailed examination of tissues and body fluids. Furthermore, PT Diagnos specializes in advanced genomics testing, such as non-invasive prenatal screening (NIPT) and preimplantation genetic testing for both aneuploidy and monogenic diseases. Beyond its core laboratory offerings, the company provides convenient home-based health check-ups, tailored corporate wellness programs, and specialized COVID-19 testing. Its broader involvement extends to supporting various healthcare initiatives and infrastructure, including maintaining specialized biological banks (e.g., eye, blood, sperm, and organ banks) and pharmacy warehousing, in collaboration with both public and private sector entities. Established in 2007, the company's headquarters are located in Jakarta Pusat, Indonesia.